Drug Development Drug Efficacy Phase 3 Trials Patient Outcomes Randomized Controlled Trials Research Studies Cancer Research Drug Approval Phase III Trials Efficacy Studies
An FDA submission is planned for Q4 2025 based on today’s wild-type cohort findings.